Kestra Medical Technologies CEO sells $443,389 of company stock

Kestra Medical Technologies CEO Brian Daniel Webster sold 15,000 shares of company stock on October 20, 2026, netting $443,389. The transactions occurred at prices between $29.5172 and $29.892 per share, as the stock neared its 52-week high of $30.00, currently trading at $28.32. The sales were executed under a pre-established Rule 10b5-1 plan, adopted on July 21, 2026.

Following the sale, Mr. Webster still holds 445,215 shares of Kestra Medical Technologies. Despite the stock appearing overvalued at current levels, the company has seen a strong 24.65% return over the past six months, with revenue soaring 60.72%. Kestra Medical remains unprofitable, with earnings per share at -$2.68 over the last twelve months.

The company has raised its full-year revenue guidance to $141 million from $137 million. Kestra Medical Technologies' shares were rated Buy and Overweight by Stifel and Piper Sandler, respectively, with price targets of $30.00 and $34.00.